CHS Bundle
Who are CHS's core patients today?
CHS shifted from rural inpatient reliance to regional hubs and outpatient growth between 2020–2024, prioritizing higher-acuity specialties and profitable markets while exiting disadvantaged areas.
CHS now targets patients in non-urban and select urban regions, with rising shares of commercially insured and outpatient encounters; key segments include cardiovascular, orthopedics, oncology, elderly with comorbidities, and behavioral health referrals.
See strategic market forces in CHS Porter's Five Forces Analysis
Who Are CHS’s Main Customers?
Primary customer segments for CHS Company concentrate on adults aged 35–74, with a strong skew to 55+ due to chronic disease prevalence; regional gender mix tracks local populations and income tilts middle to lower-middle in rural markets.
Patients (B2C)
Core patients are adults 35–74, highest utilization in 55+; payer mix typically ~28–32% Medicare, 15–18% Medicare Advantage, 12–15% Medicaid, 28–34% commercial, remainder self-pay/other.
Referral & Employer Ecosystem (B2B)
Referral sources include independent and employed physician groups, ASCs, and regional employers (manufacturing, logistics, energy); payers are national carriers and regional Blues with growing value-based contracts.
Revenue Concentration
Largest revenue share from adults 45+ with cardiometabolic, musculoskeletal, oncology and respiratory conditions; ED and surgical services feed inpatient and observation stays.
Fastest-Growing Segments
Fastest growth seen in outpatient surgery, imaging, infusion and behavioral health; commercial and Medicare Advantage cohorts drove per-encounter revenue growth post-2022.
Strategic shifts since 2017 emphasize markets with stronger demographics and employers, with >100 hospitals divested and 2021–2024 growth toward outpatient and higher-acuity lines; national Medicare Advantage penetration reached ~51% of Medicare in 2024, increasing MA exposure and contract adjustments.
Segment Details & Implications
Practical implications for targeting and analytics: prioritize older adults for inpatient and chronic-care pathways, expand outpatient capacity in growth markets, and negotiate MA contracts where penetration is rising.
- Age focus: 45–74 for revenue; 55+ for utilization
- Payer mix varies by state expansion status and market; monitor MA share
- Geography: urban/suburban hubs show higher education and white-collar mix; rural shows blue-collar/agriculture
- Referral strategy: align with local physician networks, ASCs, and regional employers
See related analysis in Marketing Strategy of CHS for further context on CHS Company customer demographics and target market.
CHS SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
What Do CHS’s Customers Want?
Customer needs center on convenient urgent and routine care, predictable costs, in‑network access, and continuity across inpatient, outpatient, and post‑acute settings; aging patients prioritize cardiac, orthopedic, oncology, and chronic care, while younger families focus on maternity, pediatrics, and urgent care. CHS customer demographics and target market demand same‑day access, price transparency, and shorter stays.
Access & Convenience
Patients expect appointments within 24–48 hours and network facilities within 15–25 minutes for routine and urgent needs.
Predictable Costs
Price transparency tools and clear out‑of‑pocket estimates drive selection, especially among commercial members who show high cost sensitivity.
Continuity of Care
Continuity across inpatient, outpatient, and post‑acute settings is prioritized by Medicare Advantage and chronic care patients for better outcomes and lower readmissions.
Digital & Ambulatory Preferences
Rising use of digital scheduling, telehealth triage, and ambulatory surgery centers; ASCs and same‑day discharge protocols lower length of stay and costs.
Quality & Reputation
Patients weigh outcomes and HCAHPS scores; clinician reputation and facility ratings strongly influence chooser behavior alongside network status.
Pain Points Addressed
CHS targets limited local access, long specialty travel, fragmented transitions, and ER crowding through telehealth, hospitalist programs, navigation, and expanded outpatient capacity.
Decision Criteria & Tailored Responses
Insurance network, clinician reputation, wait times, and total out‑of‑pocket cost drive decisions; Medicare Advantage values coordination and nonmedical benefits like transportation.
- Expanded cath lab capacity and stroke‑ready certifications in hubs to capture cardiology and neuro volume; hubs show higher procedure throughput and reduced transfers.
- Orthopedic joint programs with prehab and same‑day discharge protocols lower LOS and increase patient throughput.
- Oncology infusion centers tied to navigation reduce fragmentation and improve adherence to treatment regimens.
- Behavioral health beds and IOP programs address post‑COVID demand; telehealth triage reduces ER visits by an estimated 10–20% in pilot markets.
- Digital front door: online scheduling, pre‑registration, and payment plans for self‑pay improve conversion and reduce no‑shows.
For context on CHS Company customer demographics and how the organization evolved its market approach, see Brief History of CHS
CHS PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Where does CHS operate?
Geographical Market Presence for CHS Company centers on a network of community hospitals and outpatient hubs across the U.S., with concentration in the Southeast, Southwest and Midwest; footprint comprises approximately 70–80 hospitals in 15–17 states, focusing on non‑urban MSA‑adjacent counties where CHS often serves as the primary community provider.
Footprint
Approximately 70–80 hospitals across 15–17 states, with notable presence in Tennessee, Texas, Florida, Pennsylvania, Alabama, Mississippi, Arkansas, Indiana and Ohio; strongest brand recognition in non‑urban counties where CHS is the primary or sole hospital.
Regional Dynamics
Southeast markets show higher cardiometabolic disease prevalence and Medicaid variability affecting payer mix; Texas and Florida hubs offer faster population growth and higher commercial mix; Midwest markets have older populations with greater Medicare share and chronic care demand.
Localization
Service lines are tailored to local epidemiology and employer base; CHS forms partnerships with regional physician groups, pursues selective joint ventures for ASCs and imaging, and offers recruitment incentives for specialists in shortage areas; bilingual outreach used in growing Hispanic markets.
Portfolio Actions
Between 2017–2023 divestitures of underperforming hospitals reduced leverage and refocused capital into stronger hubs; 2023–2024 bolt‑on outpatient expansions around hubs and selective closures/service consolidations where volumes were insufficient; growth weighted to Sun Belt counties with above‑average population and Medicare Advantage penetration growth.
Market Hotspots
Tennessee, Texas and Florida act as strategic hubs for outpatient expansion and ASC scaling; these states feature faster demographic growth and higher commercial payer mixes supporting CAPEX deployment.
Rural Strength
Non‑urban MSA‑adjacent counties deliver higher market share and referral loyalty where CHS operates the primary community hospital, improving ambulatory and inpatient capture rates.
Payer Mix Impacts
Southeast Medicaid variability and Midwest Medicare concentration materially influence margins and service prioritization, prompting localized service portfolios and value‑based contracting efforts.
Telehealth & Coverage
Telehealth extends subspecialty coverage to frontier sites, reducing transfer rates and supporting chronic care management in aging Midwest populations.
Growth Strategy
Priority investment in Sun Belt counties with above‑average population and Medicare Advantage penetration growth; outpatient and imaging bolt‑ons near hubs to capture higher commercial volumes.
Further Reading
See related analysis on CHS revenue and business model: Revenue Streams & Business Model of CHS
CHS Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
How Does CHS Win & Keep Customers?
Customer Acquisition & Retention Strategies for CHS Company focus on targeted digital channels, employer and physician alignment, and service-access optimization to acquire commercial and high-value members while CRM-driven care coordination and patient-facing technology sustain retention and lifetime value.
Digital acquisition
SEO/SEM campaigns prioritize service lines such as cardiology, orthopedics and bariatrics; geotargeted ads promote new physicians and programs to capture local patient volume.
Physician & employer alignment
Employment, co-management agreements and employer outreach steer patients within payer networks and improve referral predictability.
Access & referral capture
Open scheduling templates, extended hours and rapid imaging/surgery slots reduce leakage and boost referral conversion.
Retention tactics
CRM-driven segmentation, automated recalls, 24–48 hour post-discharge follow-up and patient financial counseling lower readmissions and bad debt.
Patient experience tech
Patient portals, online scheduling and telehealth follow-ups increase retention and appointment adherence.
Care navigation
Dedicated navigation in oncology and cardiac care improves continuity and lifetime value for high-acuity cohorts.
Data & analytics
EHR analytics, CDI and CRM platforms target high-value episodes, personalize communications and track leakage; A/B testing refines campaigns.
Service recovery
Patient satisfaction monitoring links to rapid service-recovery protocols to reduce churn and improve Net Promoter Scores.
Notable initiatives
Outpatient fast-track access (same/next-day imaging and consults), cardiac and ortho centers of excellence, ED throughput programs and rural mobile screening expand reach.
Performance outcomes
Rebalancing toward outpatient and higher-acuity programs between 2022–2024 raised revenue per encounter and improved payer mix; expanded MA contracting and care coordination reduced readmissions and shortened LOS.
Key metrics & actions
Focus areas and measurable levers used to acquire and retain CHS customers.
- Targeted SEO/SEM and geotargeting to increase specialty leads and conversions
- CRM segmentation with automated recalls to close care gaps and improve retention
- Access optimization (open templates, extended hours) to reduce leakage
- Post-discharge follow-up within 24–48 hours to lower readmissions
Analytics-driven campaigns and employer/payer co-branding remain central for CHS Company customer demographics and CHS target market activation; see a market overview in Competitors Landscape of CHS.
CHS Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.